Myosteatosis and muscle loss impact liver transplant outcomes in male patients with hepatocellular carcinoma.

Background: Sarcopenia is associated with unfavourable long-term survival in patients undergoing liver transplantation (LT) for hepatocellular carcinoma (HCC). However, the impact of myosteatosis and muscle loss on patient prognosis has not been investigated.

Methods: Seven hundred fifty-six HCC patients who received LT at 3 transplant centres were included.